If you are interested in malaria control strategies and want to know more about ivermectin, come talk to me or check my poster at the 31st PAGE conference in A Coruña, Spain! 🦟💊
https://t.co/igBzNu7Up7
@inselgruppe@unibern@UniBasel@ISGLOBALorg@KEMRI_Kenya@NDMOxford
With nearly 900 registered participants and 422 submitted abstracts, the record-breaking 3️⃣1️⃣st PAGE meeting has kicked off this morning in A Corūna 🇪🇸!
With nearly 900 registered participants and 422 submitted abstracts, the record-breaking 3️⃣1️⃣st PAGE meeting has kicked off this morning in A Corūna 🇪🇸!
Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes
https://t.co/GE81O9hImp
Great work by @__CharlotteK@felixhammann@UDuthaler et al.
All in all good news for malaria vector control and certainly helpful for repurposing ivermectin for this indication.
@__CharlotteK@Carlos_Chaccour@UDuthaler
4/
Two active metabolites (M1, M4) had longer half-lives than IVM in human volunteers. This may explain why blood retains mosquitocidal activity even after IVM is no longer detectable (‘post-ivermectin effect’).
3/
Three metabolites produced by CYP3A4/5 (M1, M2, M4) were active against An. stephensi at concentrations seen in one of our prior trials in human volunteers.
2/